-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Stryker, Lowers Price Target to $365

Benzinga·10/30/2026 15:18:59
Listen to the news
Barclays analyst Christopher Pasquale maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $375 to $365.